Latest News by Industry
Intellipharmaceutics: Fiscal Q3 Earnings Snapshot
TORONTO (AP) — TORONTO (AP) — Intellipharmaceutics International Inc. (IPCIF) on Monday reported a loss of $1.9 million in its fiscal third quarter.
On a per-share basis, the Toronto-based company said it had a loss of 6 cents.
The extended-release drug developer posted revenue of $68,700 in the period. Its adjusted revenue was $69,000.